Serveur d'exploration COVID et hydrochloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Distance based and bond additive topological indices of certain repurposed antiviral drug compounds tested for treating COVID-19.

Identifieur interne : 000167 ( Main/Corpus ); précédent : 000166; suivant : 000168

Distance based and bond additive topological indices of certain repurposed antiviral drug compounds tested for treating COVID-19.

Auteurs : Jia-Bao Liu ; Micheal Arockiaraj ; M. Arulperumjothi ; Savari Prabhu

Source :

RBID : pubmed:33785968

Abstract

The entire world is struggling to control the spread of coronavirus (COVID-19) as there are no proper drugs for treating the disease. Under clinical trials, some of the repurposed antiviral drugs have been applied to COVID-19 patients and reported the efficacy of the drugs with the diverse inferences. Molecular topology has been developed in recent years as an influential approach for drug design and discovery in which molecules that are structurally related show similar pharmacological properties. It permits a purely mathematical description of the molecular structure so that in the development of identification of new drugs can be found through adequate topological indices. In this paper, we study the structural properties of the several antiviral drugs such as chloroquine, hydroxychloroquine, lopinavir, ritonavir, remdesivir, theaflavin, nafamostat, camostat, umifenovir and bevacizumab by considering the distance and bond measures of chemical compounds. Our quantitative values of the topological indices are extremely useful in the recent development of designing new drugs for COVID-19.

DOI: 10.1002/qua.26617
PubMed: 33785968
PubMed Central: PMC7995035

Links to Exploration step

pubmed:33785968

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Distance based and bond additive topological indices of certain repurposed antiviral drug compounds tested for treating COVID-19.</title>
<author>
<name sortKey="Liu, Jia Bao" sort="Liu, Jia Bao" uniqKey="Liu J" first="Jia-Bao" last="Liu">Jia-Bao Liu</name>
<affiliation>
<nlm:affiliation>School of Mathematics and Physics Anhui Jianzhu University Hefei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Arockiaraj, Micheal" sort="Arockiaraj, Micheal" uniqKey="Arockiaraj M" first="Micheal" last="Arockiaraj">Micheal Arockiaraj</name>
<affiliation>
<nlm:affiliation>Department of Mathematics Loyola College Chennai Tamil Nadu India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Arulperumjothi, M" sort="Arulperumjothi, M" uniqKey="Arulperumjothi M" first="M" last="Arulperumjothi">M. Arulperumjothi</name>
<affiliation>
<nlm:affiliation>Department of Mathematics, Loyola College University of Madras Chennai Tamil Nadu India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Prabhu, Savari" sort="Prabhu, Savari" uniqKey="Prabhu S" first="Savari" last="Prabhu">Savari Prabhu</name>
<affiliation>
<nlm:affiliation>Department of Mathematics Sri Venkateswara College of Engineering Sriperumbudur Tamil Nadu India.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33785968</idno>
<idno type="pmid">33785968</idno>
<idno type="doi">10.1002/qua.26617</idno>
<idno type="pmc">PMC7995035</idno>
<idno type="wicri:Area/Main/Corpus">000167</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000167</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Distance based and bond additive topological indices of certain repurposed antiviral drug compounds tested for treating COVID-19.</title>
<author>
<name sortKey="Liu, Jia Bao" sort="Liu, Jia Bao" uniqKey="Liu J" first="Jia-Bao" last="Liu">Jia-Bao Liu</name>
<affiliation>
<nlm:affiliation>School of Mathematics and Physics Anhui Jianzhu University Hefei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Arockiaraj, Micheal" sort="Arockiaraj, Micheal" uniqKey="Arockiaraj M" first="Micheal" last="Arockiaraj">Micheal Arockiaraj</name>
<affiliation>
<nlm:affiliation>Department of Mathematics Loyola College Chennai Tamil Nadu India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Arulperumjothi, M" sort="Arulperumjothi, M" uniqKey="Arulperumjothi M" first="M" last="Arulperumjothi">M. Arulperumjothi</name>
<affiliation>
<nlm:affiliation>Department of Mathematics, Loyola College University of Madras Chennai Tamil Nadu India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Prabhu, Savari" sort="Prabhu, Savari" uniqKey="Prabhu S" first="Savari" last="Prabhu">Savari Prabhu</name>
<affiliation>
<nlm:affiliation>Department of Mathematics Sri Venkateswara College of Engineering Sriperumbudur Tamil Nadu India.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">International journal of quantum chemistry</title>
<idno type="ISSN">0020-7608</idno>
<imprint>
<date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The entire world is struggling to control the spread of coronavirus (COVID-19) as there are no proper drugs for treating the disease. Under clinical trials, some of the repurposed antiviral drugs have been applied to COVID-19 patients and reported the efficacy of the drugs with the diverse inferences. Molecular topology has been developed in recent years as an influential approach for drug design and discovery in which molecules that are structurally related show similar pharmacological properties. It permits a purely mathematical description of the molecular structure so that in the development of identification of new drugs can be found through adequate topological indices. In this paper, we study the structural properties of the several antiviral drugs such as chloroquine, hydroxychloroquine, lopinavir, ritonavir, remdesivir, theaflavin, nafamostat, camostat, umifenovir and bevacizumab by considering the distance and bond measures of chemical compounds. Our quantitative values of the topological indices are extremely useful in the recent development of designing new drugs for COVID-19.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">33785968</PMID>
<DateRevised>
<Year>2021</Year>
<Month>04</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0020-7608</ISSN>
<JournalIssue CitedMedium="Print">
<PubDate>
<Year>2021</Year>
<Month>Feb</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>International journal of quantum chemistry</Title>
<ISOAbbreviation>Int J Quantum Chem</ISOAbbreviation>
</Journal>
<ArticleTitle>Distance based and bond additive topological indices of certain repurposed antiviral drug compounds tested for treating COVID-19.</ArticleTitle>
<Pagination>
<MedlinePgn>e26617</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/qua.26617</ELocationID>
<Abstract>
<AbstractText>The entire world is struggling to control the spread of coronavirus (COVID-19) as there are no proper drugs for treating the disease. Under clinical trials, some of the repurposed antiviral drugs have been applied to COVID-19 patients and reported the efficacy of the drugs with the diverse inferences. Molecular topology has been developed in recent years as an influential approach for drug design and discovery in which molecules that are structurally related show similar pharmacological properties. It permits a purely mathematical description of the molecular structure so that in the development of identification of new drugs can be found through adequate topological indices. In this paper, we study the structural properties of the several antiviral drugs such as chloroquine, hydroxychloroquine, lopinavir, ritonavir, remdesivir, theaflavin, nafamostat, camostat, umifenovir and bevacizumab by considering the distance and bond measures of chemical compounds. Our quantitative values of the topological indices are extremely useful in the recent development of designing new drugs for COVID-19.</AbstractText>
<CopyrightInformation>© 2021 Wiley Periodicals LLC.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Jia-Bao</ForeName>
<Initials>JB</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0002-9620-7692</Identifier>
<AffiliationInfo>
<Affiliation>School of Mathematics and Physics Anhui Jianzhu University Hefei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arockiaraj</LastName>
<ForeName>Micheal</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0002-4457-1046</Identifier>
<AffiliationInfo>
<Affiliation>Department of Mathematics Loyola College Chennai Tamil Nadu India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arulperumjothi</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0001-8557-1643</Identifier>
<AffiliationInfo>
<Affiliation>Department of Mathematics, Loyola College University of Madras Chennai Tamil Nadu India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Prabhu</LastName>
<ForeName>Savari</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0002-1922-910X</Identifier>
<AffiliationInfo>
<Affiliation>Department of Mathematics Sri Venkateswara College of Engineering Sriperumbudur Tamil Nadu India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2021</Year>
<Month>02</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Int J Quantum Chem</MedlineTA>
<NlmUniqueID>9892351</NlmUniqueID>
<ISSNLinking>0020-7608</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">COVID‐19</Keyword>
<Keyword MajorTopicYN="N">Wiener indices</Keyword>
<Keyword MajorTopicYN="N">bond additive measures</Keyword>
<Keyword MajorTopicYN="N">drugs</Keyword>
<Keyword MajorTopicYN="N">molecular descriptors</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>12</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2021</Year>
<Month>01</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2021</Year>
<Month>01</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2021</Year>
<Month>3</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>36</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2021</Year>
<Month>4</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2021</Year>
<Month>4</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">33785968</ArticleId>
<ArticleId IdType="doi">10.1002/qua.26617</ArticleId>
<ArticleId IdType="pii">QUA26617</ArticleId>
<ArticleId IdType="pmc">PMC7995035</ArticleId>
</ArticleIdList>
<pmc-dir>pmcsd</pmc-dir>
<ReferenceList>
<Reference>
<Citation>Mol Inform. 2019 Nov;38(11-12):e1900039</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31529609</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Chem Inf Comput Sci. 2003 Jul-Aug;43(4):1103-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12870899</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32074550</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Intern Emerg Med. 2020 Nov;15(8):1577-1578</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32347443</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2016 Dec 8;11(12):e0167075</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27930705</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2020 May 15;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32415251</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rev Panam Salud Publica. 2020 Mar 20;44:e40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32256547</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2020 Apr;55(4):105932</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32145363</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2020 Jun;92(6):693-697</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32167173</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Postgrad Med J. 2020 Sep;96(1139):550-555</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32295814</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4539-4547</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32373993</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Metab Syndr. 2020 May - Jun;14(3):241-246</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32247211</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Saudi Pharm J. 2017 May;25(4):580-586</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28579895</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2020 Dec;26(12):1806</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33288938</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Saudi Pharm J. 2017 May;25(4):548-555</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28579890</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2020 May 21;64(6):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32312781</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000167 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000167 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:33785968
   |texte=   Distance based and bond additive topological indices of certain repurposed antiviral drug compounds tested for treating COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:33785968" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021